Skip to main content
Top
Published in: International Journal of Clinical Oncology 2/2015

01-04-2015 | Original Article

Aggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index

Authors: Cesar Augusto Santa-Maria, Jingsheng Yan, Xian-Jin Xie, David Michael Euhus

Published in: International Journal of Clinical Oncology | Issue 2/2015

Login to get access

Abstract

Background

Obese women with estrogen receptor (ER)-positive breast cancer may experience worse disease-free and overall survival. We hypothesize that this observation is due to intrinsically aggressive disease and that obesity will be associated with higher histologic grade and Ki67.

Methods

A sequential cohort of women with breast cancer diagnosed over 2 years was assembled from institutional tumor registries. Patient and tumor characteristics were abstracted from medical records; those with non-invasive tumors, or lacking body mass index (BMI), Ki67 or histologic grade data, were excluded. Univariate and multivariate analysis was performed to investigate the relationship between markers of aggressive disease (grade and Ki67) and multiple variables associated with obesity. A subgroup analysis was performed to investigate further whether ER and menopausal status influenced associations between BMI and aggressive phenotypes.

Results

Of the 1007 patients initially identified, 668 (68 %) met the eligibility criteria. In univariate analysis, histologic grade and Ki67 were strongly associated with increased BMI, younger age, and African-American race, but less so with diabetes, hypertension, and hyperlipidemia. Multivariate analysis confirmed that higher histologic grade was associated with increased BMI (p = 0.02), and that increased Ki67 was associated with younger age (p = 0.0003) and African-American race (p = 0.002). Additional analysis found that the association between increased BMI and higher-grade tumors was particularly significant in premenopausal women with ER-positive disease.

Conclusion

This study concludes that increased BMI is associated with aggressive-phenotype breast cancer and may be particularly relevant to ER-positive breast cancer developing in premenopausal African-American women.
Literature
1.
go back to reference Food, nutrition, physical activity and the prevention of cancer: a global perspective (2007). World Cancer Research Fund/American Institute for Cancer Research, Washington, DC Food, nutrition, physical activity and the prevention of cancer: a global perspective (2007). World Cancer Research Fund/American Institute for Cancer Research, Washington, DC
2.
go back to reference Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123(3):627–635CrossRefPubMed Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123(3):627–635CrossRefPubMed
3.
4.
go back to reference Sparano JA, Wang M, Zhao F et al (2012) Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer 118(23):5937–5946CrossRefPubMedCentralPubMed Sparano JA, Wang M, Zhao F et al (2012) Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer 118(23):5937–5946CrossRefPubMedCentralPubMed
6.
go back to reference Carroll J, Protani M, Walpole E et al (2012) Effect of obesity on toxicity in women treated with adjuvant chemotherapy for early-stage breast cancer: a systematic review. Breast Cancer Res Treat 136(2):323–330. doi:10.1007/s10549-012-2213-3 PubMed Carroll J, Protani M, Walpole E et al (2012) Effect of obesity on toxicity in women treated with adjuvant chemotherapy for early-stage breast cancer: a systematic review. Breast Cancer Res Treat 136(2):323–330. doi:10.​1007/​s10549-012-2213-3 PubMed
7.
9.
go back to reference Chlebowski R, McTiernan A, Wactawski-Wende J et al (2012) Diabetes, metformin, and breast cancer in postmenopausal women. J Clin Oncol 30(23):2844–2852CrossRefPubMedCentralPubMed Chlebowski R, McTiernan A, Wactawski-Wende J et al (2012) Diabetes, metformin, and breast cancer in postmenopausal women. J Clin Oncol 30(23):2844–2852CrossRefPubMedCentralPubMed
10.
go back to reference Khan S, Shukla S, Sinha S et al (2013) Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. Cytokine Growth Factor Rev 24(6):503–513CrossRefPubMed Khan S, Shukla S, Sinha S et al (2013) Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. Cytokine Growth Factor Rev 24(6):503–513CrossRefPubMed
11.
go back to reference Yanai A, Miyagawa Y, Murase K et al (2013) Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers. Int J Clin Oncol [Epub ahead of print] Yanai A, Miyagawa Y, Murase K et al (2013) Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers. Int J Clin Oncol [Epub ahead of print]
12.
go back to reference Obesity: preventing and managing the global epidemic. Report of a WHO consultation (2000) vol 894 Obesity: preventing and managing the global epidemic. Report of a WHO consultation (2000) vol 894
13.
go back to reference IOM (Institute of Medicine): the role of obesity in cancer survival and recurrence: workshop summary. (2012) Washington, DC IOM (Institute of Medicine): the role of obesity in cancer survival and recurrence: workshop summary. (2012) Washington, DC
14.
go back to reference Flegal KM, Carroll MD, Kit BK et al (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307(5):491–497CrossRefPubMed Flegal KM, Carroll MD, Kit BK et al (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307(5):491–497CrossRefPubMed
15.
go back to reference Wing RR, Matthews KA, Kuller LH et al (1991) Weight gain at the time of menopause. Arch Intern Med 151(1):97–102CrossRefPubMed Wing RR, Matthews KA, Kuller LH et al (1991) Weight gain at the time of menopause. Arch Intern Med 151(1):97–102CrossRefPubMed
16.
go back to reference Dawood S, Lei X, Litton JK et al (2012) Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer. Clin Breast Cancer 12(5):364–372CrossRefPubMed Dawood S, Lei X, Litton JK et al (2012) Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer. Clin Breast Cancer 12(5):364–372CrossRefPubMed
17.
go back to reference Ries LAG, Eisner MP, Kosary CL (2001) SEER cancer statistics review, 1973–1998, National Cancer Institute Ries LAG, Eisner MP, Kosary CL (2001) SEER cancer statistics review, 1973–1998, National Cancer Institute
18.
go back to reference CDC (2011) Vital signs: prevalence, treatment, and control of hypertension—United States, 1999–2002 and 2005–2008. MMWR 60(4):103–108 CDC (2011) Vital signs: prevalence, treatment, and control of hypertension—United States, 1999–2002 and 2005–2008. MMWR 60(4):103–108
19.
go back to reference Kuklina EV, Shaw KM, Hong Y (2011) Vital Signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol—United States, 1999–2002 and 2005–2008. MMWR 60(04):109–114 Kuklina EV, Shaw KM, Hong Y (2011) Vital Signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol—United States, 1999–2002 and 2005–2008. MMWR 60(04):109–114
20.
go back to reference Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States (2011) U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States (2011) U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA
21.
go back to reference Christiansen N, Chen L, Gilmore J et al (2012) Association between African American race and outcomes in patients with nonmetastatic triple-negative breast cancer: a retrospective analysis by using results from the Georgia Cancer Specialist Database. Clin Breast Cancer 12(4):270–275CrossRefPubMed Christiansen N, Chen L, Gilmore J et al (2012) Association between African American race and outcomes in patients with nonmetastatic triple-negative breast cancer: a retrospective analysis by using results from the Georgia Cancer Specialist Database. Clin Breast Cancer 12(4):270–275CrossRefPubMed
22.
go back to reference Sparano JA, Wang M, Zhao F et al (2012) Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial. J Natl Cancer Inst 104(5):406–414CrossRefPubMedCentralPubMed Sparano JA, Wang M, Zhao F et al (2012) Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial. J Natl Cancer Inst 104(5):406–414CrossRefPubMedCentralPubMed
23.
go back to reference Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403–410CrossRefPubMed Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403–410CrossRefPubMed
24.
go back to reference Deurenberg P, Yap M, van Staveren WA (1998) Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 22(12):1164–1171CrossRefPubMed Deurenberg P, Yap M, van Staveren WA (1998) Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 22(12):1164–1171CrossRefPubMed
25.
go back to reference Abbasi F, Blasey C, Reaven GM (2013) Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity? Am J Clin Nutr 98(3):637–640CrossRefPubMedCentralPubMed Abbasi F, Blasey C, Reaven GM (2013) Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity? Am J Clin Nutr 98(3):637–640CrossRefPubMedCentralPubMed
28.
go back to reference Meyer JS, Alvarez C, Milikowski C et al (2005) Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Mod Pathol 18(8):1067–1078CrossRefPubMed Meyer JS, Alvarez C, Milikowski C et al (2005) Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Mod Pathol 18(8):1067–1078CrossRefPubMed
29.
go back to reference Moller DE, Flier JS (1991) Insulin resistance—mechanisms, syndromes, and implications. N Engl J Med 325(13):938–948CrossRefPubMed Moller DE, Flier JS (1991) Insulin resistance—mechanisms, syndromes, and implications. N Engl J Med 325(13):938–948CrossRefPubMed
31.
32.
go back to reference Cho Y, Sung M, Yeon J et al (2013) Prognostic role of interleukin-6, interleukin-8, and leptin levels according to breast cancer subtype. Cancer Res Treat 45(3):210–219CrossRefPubMedCentralPubMed Cho Y, Sung M, Yeon J et al (2013) Prognostic role of interleukin-6, interleukin-8, and leptin levels according to breast cancer subtype. Cancer Res Treat 45(3):210–219CrossRefPubMedCentralPubMed
Metadata
Title
Aggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index
Authors
Cesar Augusto Santa-Maria
Jingsheng Yan
Xian-Jin Xie
David Michael Euhus
Publication date
01-04-2015
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 2/2015
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-014-0712-4

Other articles of this Issue 2/2015

International Journal of Clinical Oncology 2/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine